CLINICAL CASE OF NEONATAL THYROTOXICOSIS
https://doi.org/10.21508/1027-4065-2018-63-5-183-187
Abstract
Neonatal thyrotoxicosis is 1% of all cases of thyrotoxicosis in children and adolescents and it is mostly determined by the mother’s Graves’ disease. The most dangerous manifestations of neonatal thyrotoxicosis are intrauterine growth retardation, tachycardia, and heart rhythm disturbances. Timely diagnostics and beginning of treatment are of great importance due to the high risk of fatal cardiac disruption in the acute phase of the disease and its serious consequences for the body. The article presents a clinical case of a patient with neonatal thyrotoxicosis diagnosed only at the age of 1 month, despite the mother’s burdened anamnesis; it contains a plan for diagnostic search and tactics of child management.
About the Authors
M. R. ShaydullinaRussian Federation
A. R. Shakirova
Russian Federation
A. A. Zinatullina
Russian Federation
References
1. Chandar M.В. Fetal and neonatal thyrotoxicosis. Indian J Endocrinol Metab 2013; 17(Suppl 1): S50–S54. DOI: 10.4103/2230-8210.119505
2. Lourenço R., Dias P., Gouveia R., Sousa A.B., Oliveira G. Neonatal McCune-Albright syndrome with systemic involvement: a case report. J Med Case Rep2015; 9: 189.
3. Kurtoğlu S., ÖzdemirА. Fetal neonatal hyperthyroidism Turk Pediatri Ars 2017; 52: 1–9. DOI: 10.5152/TurkPediatriArs.2017.2513
4. Bulow Pedersen I., Laurberg P. Biochemical hyperthyroidism in a newborn baby by interaction from biotin intake. Eur Throid J2016; 5: 212–215.
5. Kiefer F.W., Klebermass-Schrehof K., Steiner M., Worda C., Kasprian G., Diana T. et al. Fetal/Neonatal Thyrotoxicosis in a Newborn From a Hypothyroid Woman With Hashimoto Thyroiditis. J Clin Endocrinol Metabol 2017; 102(1): 6–9. DOI: 10.1210/jc.2016-2999
6. Van der Kaay D.C., Wasserman J.D., Palmert M.R. Management of neonates born to mothers with Graves’ disease. Pediatrics2016; 137(4). DOI: 10.1542/peds.2015-1878.
7. Levy-Shraga Y., Tamir-Hostovsky L., Boyko V., Lerner-Geva L., Pinhas-Hamiel O. Follow-up of newborns of mothers with Graves’ disease. Thyroid2014; 24: 1032–1039.
8. van Dijk M.M., Smits I.H., Fliers E., Bisschop P.H. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review. Thyroid2018; 28(2): 257–264. DOI: 10.1089/thy.2017.0413
9. Besançon A., Beltrand J., Le Gac I., Luton D., Polak M. Management of neonates born to women with Graves’ disease: a cohort study. Eur J Endocrinol2014; 170: 855–862.
10. Bahn Chair R.S., Burch H.B., Cooper D.S., Garber J.R., Greenlee M.C., Klein I., Laurberg P. et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011; 21: 593–646. DOI: 10.1089/thy.2010.0417
11. Rivkees S.A., Stephenson K., Dinauer C. Adverse events associated with methimazole therapy of graves’ disease in children. Int J Pediatr Endocrinol 2010; 2010: 176970. DOI: 10.1155/2010/176970
12. Törnhage C.J., Grankvist K. Acquired neonatal thyroid disease due to TSH receptor antibodies in breast milk. J Pediatr Endocrinol Metab2006; 19: 787–794.
13. Stagnaro-Green А., Abalovich М., Аlexander E., Аzizi F., Mestman J., Negro R., Nixon А. et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 1081–1125. DOI: 10.1089/thy.2011.0087
Review
For citations:
Shaydullina M.R., Shakirova A.R., Zinatullina A.A. CLINICAL CASE OF NEONATAL THYROTOXICOSIS. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2018;63(5):183-187. (In Russ.) https://doi.org/10.21508/1027-4065-2018-63-5-183-187